Eaton R P
Diabetes. 1976 Jan;25(1):32-43. doi: 10.2337/diab.25.1.32.
Characterization of specificity of incorporation of 75Se-selenomethionine into human apoproteins following in-vivo injection of the radioactive amino acid precursor is reported. Apoprotein fractionation was attained by serial ultracentrifugation, anhydrous partial delipidization, decyl sulfate solubilization with Sephadex G-150 gel filtration into polypeptide fractions, Sf-I, and Sf-II, for VLDL, and LDL subfractions. Similarity of the Sf-I fractions isolated from VLDL, LDL1, and LDL2 was defined by gel exclusion volume, disk-gel electrophoresis, immunodiffusion, and amino acid composition. Enrichment of the Sf-I fractions with 75Se-SM in VLDL and LDL subfractions was observed, suggesting a possible use for this isotopic method for the investigation of apoprotein metabolism.
报告了在体内注射放射性氨基酸前体后,75Se-硒蛋氨酸掺入人载脂蛋白的特异性特征。通过连续超速离心、无水部分脱脂、用癸基硫酸盐增溶并经Sephadex G-150凝胶过滤将载脂蛋白分级分离为VLDL和LDL亚组分的多肽级分Sf-I和Sf-II。从VLDL、LDL1和LDL2分离出的Sf-I级分的相似性通过凝胶排阻体积、圆盘凝胶电泳、免疫扩散和氨基酸组成来确定。观察到VLDL和LDL亚组分中的Sf-I级分被75Se-SM富集,表明这种同位素方法可能用于研究载脂蛋白代谢。